24/7 BIOPHARMA -issue 1 / March 2025

68TWENTYFOURSEVENBIOPHARMA Issue 1 / March 2025 TJOAPACK 24/7 BIOPHARMA caught up with Marcelo Cruz, Vice President of Marketing and Business Development at Tjoapack, a contract packaging organization, at CPHI Milan. Tjoapack has packaging facilities in both the United States and the Netherlands. Our conversation opened with a discussion on flexibility, which every contract organization professes but few acutely explain. According to Cruz, Tjoapack’s approach is built on a discussionoriented model where, if needed, bespoke solutions can be designed via a collaborative process. “The flexibility in our case is that we try to find solutions together with clients,” said Cruz. “For instance, we just talked to a client a few minutes ago that we’re going to have a brainstorming session between their SMEs. We’re going to lock ourselves in the room and go through the whole supply chain process to try to find an effective solution for [the] issue that they are having. Now it’s a very complex project, it’s a pre-filled syringe that needs sterilization. It needs to have these constraints created for different markets. So it’s something that not many people can do, and we can help them in that.” In this vein, Cruz also believes that Tjoapack benefits from being a small-to-medium sized company. Larger companies, by nature of their scale, have less ability to modify their processes on a customer-by-customer basis, which can lead to complications when dealing with more specialized products. For Tjoapack, this provides them a niche that they can operate in, while still allowing for scale and growth through its complementary offerings in the oral solid dosage business.

RkJQdWJsaXNoZXIy MjY2OTA4MA==